DualityBio
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DualityBio - overview
Established
2020
Location
Suzhou, Jiangsu, China
Primary Industry
Biotechnology
About
Founded in 2020 and based in Suzhou, China, Duality Biologics operates as a provider of innovative molecular drug that provides bispecific antibody drugs. The company has branch offices in Shanghai and Beijing, and has cooperated with 3SBio Inc. , BioNTech, etc. It has acquired FTD, ODD, IND and other certifications.
The founder, chairman of the board and CEO, Zhu Zhongyuan, is a doctor of the University of Massachusetts Medical School, and has worked in Mingxin Capital, SIG Asia Investment Fund, etc. In April 2025, it raised CNY 1. 64 billion in an IPO, selling 17. 33 million shares at CNY 94.
6 per share on the Hong Kong Stock Exchange. The company has developed DITAC, DIBAC, DIMAC, DUPAC and other technology platforms. Products include dual-antibody ADC, new mechanism-loaded ADC and autoimmune ADC. Its technologies and products can be used to treat cancer and autoimmune diseases.
The company generates revenue by providing dual-antibody ADC, new mechanism-loaded ADC and autoimmune ADC.
Current Investors
6 Dimensions Capital, King Star Capital, WuXi Biologics (Cayman) Inc.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.dualitybiologics.com
Verticals
Clean Technology
Company Stage
Series B
Total Amount Raised
Subscriber access only
DualityBio - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPO | Completed | DualityBio | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.